SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,314.59 -21.86
( -0.03%)

Global Indices

Nasdaq

51,795.38 312.48
(0.61%)

Dow Jones

7,657.54 84.73
(1.12%)

Hang Seng

63,960.24 37.24
(0.06%)

Nikkei 225

10,816.25 127.78
(1.20%)

Forex

USD-INR

95.42 0.14
(0.14%)

EUR-INR

110.10 0.01
(0.01%)

GBP-INR

128.62 0.03
(0.02%)

JPY-INR

0.62 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.8745685

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

50.45

665.82

EPS(TTM)

Face Value()

Div & Yield %

2.43

Back

cinevista ltd

Bajaj Finance consolidated net profit rises 27.37% in the June 2026 quarter

Aug 21,2026

Net profit of Bajaj Finance rose 27.37% to Rs 5985.75 crore in the quarter ended June 2026 as against Rs 4699.61 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 23023.46 crore in the quarter ended June 2026 as against Rs 19255.19 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	23023.46	19255.19	20
OPM %	71.11	70.28	-
PBDT	8436.55	6619.07	27
PBT	8149.00	6367.58	28
NP	5985.75	4699.61	27

74,314.59 -21.86 ( -0.03%)

51,795.38 312.48 (0.61%)

7,657.54 84.73 (1.12%)

63,960.24 37.24 (0.06%)

10,816.25 127.78 (1.20%)

95.42 0.14 (0.14%)

110.10 0.01 (0.01%)

128.62 0.03 (0.02%)

0.62 0.00 (-0.26%)